跳至主要内容
临床试验/NCT02871986
NCT02871986Unknown不适用

Variability of Uterine and Breast Development in Response to Exogenous Oestrogen During Induction of Puberty in Individuals With Hypogonadism.

University College, London1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2016年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
24
试验地点
1
主要终点
Uterine dimensions and volume

研究概览

简要总结

The investigators wish to explore the variability of uterine, breast and bone outcome markers as surrogates to assess the adequacy of exogenous oestrogen replacement in individuals with hypogonadism.

详细描述

The investigators will invite individuals with hypogonadism who require pubertal induction to participate in the study. The participants will receive conventional routine oestrogen replacement in the form of transdermal patch. The participants will be reviewed every 2 months for a total of 8 months to document uterine, breast and bone assessment. This will be completed using a variety of tools. After 4 months, the participants will receive an incremental increase in oestrogen dose.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
10 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Have a diagnosis of hypogonadism (Turner's syndrome, hypogonadotrophic hypogonadism, primary ovarian insufficiency, hypopituitarism, hypothalamic amenorrhoea, transgender)
  • ≥ 10 years of age
  • Oestrogen naïve i.e. no prior commencement of oestrogen treatment
  • Breast Tanner stage ≤ than 2

排除标准

  • Previous oncology treatment
  • Primary amenorrhoea secondary to chronic medical comorbidity
  • PCOS diagnosis

研究组 & 干预措施

Individuals with hypogonadism

Individuals with hypogonadism requiring pubertal induction. Participants will receive oestrogen therapy in the form of transdermal oestrogen patch, which is standard care.

干预措施: Routine transdermal oestrogen patch (Drug)

结局指标

主要结局

Uterine dimensions and volume

时间窗: Assessment every 2 months for a total of 8 months

transabdominal ultrasound

次要结局

  • Breast Volume assessment(Assessed every 2 months for a total of 8 months)
  • Height(Assessed every 2 months for a total of 8 months)
  • Bone health(Assessed at baseline and at 8 months)
  • Pubertal assessment - Tanner staging(Assessed every 2 months for a total of 8 months)
  • Hormonal profile and bone turnover markers(Assessed every 2 months for a total of 8 months)
  • Inter and intra observer reproducibility of uterine and ovarian measurements in transabdominal ultrasound(Assessed once during the 8 month study period)
  • Weight(Assessed every 2 months for a total of 8 months)
  • BMI(Assessed every 2 months for a total of 8 months)
  • Waist and hip circumference(Assessed every 2 months for a total of 8 months)
  • Body fat composition(Assessed every 2 months for a total of 8 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pubertal Induction in Individuals With Hypogonadism | 临床试验